Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Biochem Biophys ; 549: 40-8, 2014 May 01.
Article in English | MEDLINE | ID: mdl-24686197

ABSTRACT

Homotrimeric mammalian purine nucleoside phosphorylase (PNP) plays a key role in the nucleoside and nucleotide metabolic salvage pathway. Each monomer in the active PNP trimer is composed of a central ß-sheet flanked by several α-helices. We investigated the stability of calf PNP using analytical ultracentrifugation, differential scanning calorimetry, circular dichroism, and UV absorption spectroscopy. The results demonstrate that the activity decline (due to protein aging after isolation from cells) of wild type PNP and its two mutants with point mutations in the region of monomer-monomer interface, is accompanied by a decrease of the population of the trimeric enzyme and an increase of the population of its aggregated forms. The data do not indicate a significant population of either folded or unfolded PNP monomers. The enzyme with specific activity lower than the maximal shows a decrease of the helical structure, which can make it prone to aggregation. The presence of phosphate stabilizes the enzyme but leads to a more pronounced aggregation above the melting temperature. These results suggest that the biological role of packing of the PNP monomers into a trimeric structure is to provide the stability of the enzyme since the monomers are not stable in solution.


Subject(s)
Protein Multimerization , Purine-Nucleoside Phosphorylase/chemistry , Purine-Nucleoside Phosphorylase/metabolism , Amino Acid Sequence , Animals , Cattle , Models, Molecular , Molecular Sequence Data , Mutation , Protein Denaturation , Protein Structure, Quaternary , Purine-Nucleoside Phosphorylase/genetics
2.
Bioorg Med Chem ; 20(22): 6758-69, 2012 Nov 15.
Article in English | MEDLINE | ID: mdl-23040896

ABSTRACT

Transition-state analogue inhibitors, immucillins, were reported to bind to trimeric purine nucleoside phosphorylase (PNP) with the stoichiometry of one molecule per enzyme trimer [Miles, R. W.; Tyler, P. C.; Furneaux, R. H.; Bagdassarian, C. K.; Schramm, V. L. Biochem. 1998, 37, 8615]. In attempts to observe and better understand the nature of this phenomenon we have conducted calorimetric titrations of the recombinant calf PNP complexed with immucillin H. However, by striking contrast to the earlier reports, we have not observed negative cooperativity and we got the stoichiometry of three immucillin molecules per enzyme trimer. Similar results were obtained from fluorimetric titrations, and for other inhibitors bearing features of the transition state. However, we observed apparent cooperativity between enzyme subunits and apparent lower stoichiometry when we used the recombinant enzyme not fully purified from hypoxanthine, which is moped from Escherichia coli cells. Results presented here prove that one-third-of-the-sites binding does not occur for trimeric PNP, and give the highly probable explanation why previous experiments were interpreted in terms of this phenomenon.


Subject(s)
Purine-Nucleoside Phosphorylase/metabolism , Animals , Binding Sites , Calorimetry , Catalytic Domain , Cattle , Fluorometry , Hypoxanthine/chemistry , Hypoxanthine/metabolism , Ligands , Purine Nucleosides/chemistry , Purine Nucleosides/metabolism , Purine-Nucleoside Phosphorylase/chemistry , Purine-Nucleoside Phosphorylase/genetics , Pyrimidinones/chemistry , Pyrimidinones/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Thermodynamics
3.
FEBS J ; 277(7): 1747-60, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20193043

ABSTRACT

Genetic deficiency of purine nucleoside phosphorylase (PNP; EC 2.4.2.1) activity leads to a severe selective disorder of T-cell function. Therefore, potent inhibitors of mammalian PNP are expected to act as selective immunosuppressive agents against, for example, T-cell cancers and some autoimmune diseases. 9-(5',5'-difluoro-5'-phosphonopentyl)-9-deazaguanine (DFPP-DG) was found to be a slow- and tight-binding inhibitor of mammalian PNP. The inhibition constant at equilibrium (1 mm phosphate concentration) with calf spleen PNP was shown to be = 85 +/- 13 pm (pH 7.0, 25 degrees C), whereas the apparent inhibition constant determined by classical methods was two orders of magnitude higher ( = 4.4 +/- 0.6 nm). The rate constant for formation of the enzyme/inhibitor reversible complex is (8.4 +/- 0.5) x 10(5) m(-1).s(-1), which is a value that is too low to be diffusion-controlled. The picomolar binding of DFPP-DG was confirmed by fluorimetric titration, which led to a dissociation constant of 254 pm (68% confidence interval is 147-389 pm). Stopped-flow experiments, together with the above data, are most consistent with a two-step binding mechanism: E + I <--> (EI) <--> (EI)*. The rate constants for reversible enzyme/inhibitor complex formation (EI), and for the conformational change (EI) <--> (EI)*, are k(on1) = (17.46 +/- 0.05) x 10(5) m(-1).s(-1), k(off1) = (0.021 +/- 0.003) s(-1), k(on2) = (1.22 +/- 0.08) s(-1) and k(off2) = (0.024 +/- 0.005) s(-1), respectively. This leads to inhibition constants for the first (EI) and second (EI)* complexes of K(i) = 12.1 nM (68% confidence interval is 8.7-15.5 nm) and = 237 pm (68% confidence interval is 123-401 pm), respectively. At a concentration of 10(-4) m, DFPP-DG exhibits weak, but statistically significant, inhibition of the growth of cell lines sensible to inhibition of PNP activity, such as human adult T-cell leukaemia and lymphoma (Jurkat, HuT78 and CCRF-CEM). Similar inhibitory activities of the tested compound were noted on the growth of lymphocytes collected from patients with Hashimoto's thyroiditis and Graves' disease. The observed weak cytotoxicity may be a result of poor membrane permeability.


Subject(s)
Clodronic Acid/analogs & derivatives , Guanine/analogs & derivatives , Purine-Nucleoside Phosphorylase/chemistry , Biochemistry/methods , Cell Line, Tumor , Cell Membrane/metabolism , Clodronic Acid/chemistry , Endocytosis , Guanine/chemistry , Humans , Jurkat Cells , Kinetics , Lymphocytes/metabolism , Models, Chemical , Organophosphonates/chemistry , Permeability , Protein Binding , Purine-Nucleoside Phosphorylase/adverse effects
4.
Biochem Biophys Res Commun ; 391(1): 703-8, 2010 Jan 01.
Article in English | MEDLINE | ID: mdl-19944078

ABSTRACT

Low molecular mass purine nucleoside phosphorylases (PNPs, E.C. 2.4.2.1) are homotrimeric enzymes that are tightly inhibited by immucillins. Due to the positive charge on the ribose like part (iminoribitol moiety) and protonation of the N7 atom of the purine ring, immucillins are believed to act as transition state analogues. Over a wide range of concentrations, immucillins bind with strong negative cooperativity to PNPs, so that only every third binding site of the enzyme is occupied (third-of-the-sites binding). 9-(5',5'-difluoro-5'-phosphonopentyl)-9-deazaguanine (DFPP-DG) shares with immucillins the protonation of the N7, but not the positive charge on the ribose like part of the molecule. We have previously shown that DFPP-DG interacts with PNPs with subnanomolar inhibition constant. Here, we report additional biochemical experiments to demonstrate that the inhibitor can be bound with the same K(d) ( approximately 190pM) to all three substrate binding sites of the trimeric PNP, and a crystal structure of PNP in complex with DFPP-DG at 1.45A resolution, the highest resolution published for PNPs so far. The crystals contain the full PNP homotrimer in the asymmetric unit. DFPP-DG molecules are bound in superimposable manner and with full occupancies to all three PNP subunits. Thus the postulated third-of-the-sites binding of immucillins should be rather attribute to the second feature of the transition state, ribooxocarbenium ion character of the ligand or to the coexistence of both features characteristic for the transition state. The DFPP-DG/PNP complex structure confirms the earlier observations, that the loop from Pro57 to Gly66 covering the phosphate-binding site cannot be stabilized by phosphonate analogues. The loop from Glu250 to Gln266 covering the base-binding site is organized by the interactions of Asn243 with the Hoogsteen edge of the purine base of analogues bearing one feature of the postulated transition state (protonated N7 position).


Subject(s)
Enzyme Inhibitors/chemistry , Guanine/analogs & derivatives , Organophosphonates/chemistry , Purine-Nucleoside Phosphorylase/chemistry , Recombinant Proteins/chemistry , Animals , Binding Sites , Cattle , Crystallography, X-Ray , Enzyme Inhibitors/pharmacology , Glutamic Acid/chemistry , Glutamine/chemistry , Glycine/chemistry , Guanine/chemistry , Guanine/pharmacology , Organophosphonates/pharmacology , Phosphates/chemistry , Protein Multimerization , Purine-Nucleoside Phosphorylase/antagonists & inhibitors , Recombinant Proteins/antagonists & inhibitors , Ribose/chemistry
5.
Biochem Biophys Res Commun ; 391(2): 1203-9, 2010 Jan 08.
Article in English | MEDLINE | ID: mdl-20005207

ABSTRACT

Calf purine nucleoside phosphorylase (PNP) was overexpressed in Escherichia coli. The basic kinetic parameters of recombinant PNP were found to be similar to the values published previously for non-recombinant PNP from calf spleen. However, upon titration of the recombinant enzyme with the tight-binding multisubstrate analogue inhibitor DFPP-DG, endothermic as well as exothermic signals were obtained. This was not the case for PNP isolated from calf spleen for which only the endothermic process was observed. Further calorimetric titrations of the recombinant and non-recombinant enzyme with its potent and moderate ligands, and studied involving partial inactivation of the enzyme, lead to the conclusion that a part of the recombinant enzyme forms a complex with its product, hypoxanthine, although hypoxanthine was not present at any purification stage except for its natural occurrence in E. coli cells. Binding of hypoxanthine is accompanied with a large negative change of the free enthalpy, and therefore the replacement of this compound by DFPP-DG yields positive heat signal. Our data obtained with calf PNP indicate that similar processes--moping of ligands from the host cells--may take place in the case of other proteins with high overexpression yield.


Subject(s)
Hypoxanthine/chemistry , Purine-Nucleoside Phosphorylase/biosynthesis , Purine-Nucleoside Phosphorylase/chemistry , Recombinant Proteins/chemistry , Thermodynamics , Animals , Calorimetry , Cattle , Chromatography, Affinity , Escherichia coli/genetics , Escherichia coli/metabolism , Hypoxanthine/isolation & purification , Hypoxanthine/metabolism , Ligands , Protein Folding , Purine-Nucleoside Phosphorylase/isolation & purification , Recombinant Proteins/biosynthesis , Recombinant Proteins/isolation & purification , Spleen/enzymology
6.
Nucleic Acids Symp Ser (Oxf) ; (52): 663-4, 2008.
Article in English | MEDLINE | ID: mdl-18776554

ABSTRACT

The Gibbs binding energy and entropy/enthalpy contributions to the interaction of calf spleen purine nucleoside phosphorylase (PNP) with the novel multisubstrate analogue DFPP-DG, as well as with DFPP-G and (S)-PMP-DAP were determined by fluorescence and calorimetric studies. Results were compared with findings for guanine - a natural reaction product and inhibitor.


Subject(s)
Adenine/analogs & derivatives , Enzyme Inhibitors/chemistry , Guanine/analogs & derivatives , Organophosphonates/chemistry , Organophosphorus Compounds/chemistry , Purine-Nucleoside Phosphorylase/chemistry , Adenine/chemistry , Animals , Guanine/chemistry , Purine-Nucleoside Phosphorylase/antagonists & inhibitors , Spleen/enzymology , Thermodynamics
7.
Nucleic Acids Symp Ser (Oxf) ; (52): 671-2, 2008.
Article in English | MEDLINE | ID: mdl-18776558

ABSTRACT

The steady-state fluorimetric titration curves for trimeric purine nucleoside phosphorylase (PNP) by two ligands, were analysed using the DynaFit program. Results of this analysis indicate that three binding sites of PNP molecule interact with each other and that the character of this interaction is different for both ligands. The DynaFit program is very useful in studies of oligomeric proteins, but for detection of non-interacting sites some independent tests are necessary.


Subject(s)
Purine-Nucleoside Phosphorylase/chemistry , Software , Spectrometry, Fluorescence , Binding Sites , Guanine/chemistry , Ligands , Thioguanine/analogs & derivatives , Thioguanine/chemistry , Titrimetry
8.
Protein Expr Purif ; 61(2): 122-30, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18585465

ABSTRACT

Calf PNP is a ubiquitous enzyme of the salvage metabolic pathway. The procedure for this enzyme production in large quantities is described. The coding sequence of bovine PNP was amplified from the calf spleen cDNA library and was inserted into an expression vector pET28a(+). The construct was transformed into Escherichia coli BL21(DE3) strain. The protein expression efficiencies in the presence and the absence of IPTG were compared. It was found that IPTG is not necessary for obtaining a large quantity of recombinant calf PNP: 35 mg from 1L cell culture. The enzyme was purified to 92% homogeneity by a two-step procedure consisting of gel filtration and ion exchange chromatography. The purity of recombinant enzyme is sufficient to form well diffracting single crystals. The basic kinetic parameters of recombinant PNP were determined and compared with the parameters of commercially available PNP from calf spleen. The specific activity in 50 mM phosphate buffer with inosine as a variable substrate (30.7 micromol min(-1)mg(-1)) and other kinetic parameters: Michaelis constants, maximal velocities, dissociation and inhibition constants, determined for several typical PNP ligands, are similar to the values published previously for non-recombinant calf spleen PNP. As expected for mammalian PNP, recombinant calf PNP was found to have no substrate activity vs adenosine. The overexpression and purification method of the recombinant calf PNP provides significant amounts of the enzyme, which can successfully replace the non-recombinant PNP.


Subject(s)
Gene Expression , Purine-Nucleoside Phosphorylase/chemistry , Purine-Nucleoside Phosphorylase/isolation & purification , Animals , Cattle , Cloning, Molecular , Crystallization , DNA, Complementary/genetics , Escherichia coli/genetics , Guanine/analogs & derivatives , Guanine/chemistry , Hypoxanthine/chemistry , Inosine/chemistry , Kinetics , Mass Spectrometry , Phosphates/chemistry , Phosphates/metabolism , Polymerase Chain Reaction/methods , Purine-Nucleoside Phosphorylase/genetics , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...